| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/16/2004 | US20040253675 Method for GPCR assay with a coexpressed Galpha protein |
| 12/16/2004 | US20040253667 Expression vector comprising nuclelotide sequences coding membrane protein for use in identifying modulator for treatment of cell proliferative, nervous system and inflammatory diseases |
| 12/16/2004 | US20040253666 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/16/2004 | US20040253659 Method for identification of glycosylated polypeptides |
| 12/16/2004 | US20040253657 Simultaneous screening of multiple analytes |
| 12/16/2004 | US20040253656 Method for measuring inositol triphosphate |
| 12/16/2004 | US20040253655 Immunoassay for use in detection high blood pressure; immunodiagnostics |
| 12/16/2004 | US20040253653 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents; immunotherapy |
| 12/16/2004 | US20040253651 Detected from secreted glycoprotein (such as matrix metalloproteinases, prostate specific antigen, kallikrein 2, human chorionic gonadotrophin or carcinoembryonic antigen); glycosyltransferases; for diagnosing and targeting cell proliferative disorders; vaccines |
| 12/16/2004 | US20040253650 White blood cell functional assay |
| 12/16/2004 | US20040253649 Determing concentration of cellular protein in tissues by means of density imaging in conjunction with immunohistological staining; tumor suppressor protein staining profile and cancer treatment and/or progression |
| 12/16/2004 | US20040253648 Method for creating nuclear receptor activity modulating pharmaceuticals |
| 12/16/2004 | US20040253647 Evaluating modulators effectiveness as treatment for alzheimer's via quantifying amyloid precursor protein peptide cleavage products present after exposure agonist/antagonist |
| 12/16/2004 | US20040253646 Pre-mrna splicing screening assay |
| 12/16/2004 | US20040253643 Using ratio of neurofibrillary tangle to amyloid beta protein in cerebrospinal fluid as diagnostic indicator of nervous system disorders; immunodiagnostics |
| 12/16/2004 | US20040253642 Using multizonal bioassay to screen compounds singly or in combination, so as to, monitor safety, pharmacological and/or toxicity profiles of test compounds; drug screening |
| 12/16/2004 | US20040253641 Crystals and structures of ephrin receptor EPHA7 |
| 12/16/2004 | US20040253640 Using microwave irradiation to heat and immobilize protein chips onto slide; solid supports for disease detection |
| 12/16/2004 | US20040253637 Markers for differential diagnosis and methods of use thereof |
| 12/16/2004 | US20040253636 Identifying preferential protein in mixture; comprising isoelectric focusing, using carrier ampholytes and/or immobilised pH gradients, followed by size separation using polyacrylamide gel electrophoresis and confirming protein identification via mass spectrum analysis; proteomics |
| 12/16/2004 | US20040253635 Contacting libraries with tag (green/blue fluorescent protein, horseradish peroxidase) to form complex, incubating, then identifying competitive binding agents |
| 12/16/2004 | US20040253634 Novel microarrays and methods of use thereof |
| 12/16/2004 | US20040253632 Identifying compounds that modulate an immune complex comprising lymphocyte receptor (TCR) and a major histocompatibility complex (MHC) antigen; immunodiagnostics; immunotherapy; high throughput assay; treating autoimmune and allergenic disorders |
| 12/16/2004 | US20040253630 Using macrophage surface receptor genes as diagnostic and therapeutic tools in treatment of inflammatory and respiratory system disorders |
| 12/16/2004 | US20040253627 System and method for multidimensional evaluation of combinations of compositions |
| 12/16/2004 | US20040253626 Using invasive trophoblastic antigen (ITA) and human chorionic gonadotropin (hCG) isoform concentration as diagnostic indicators of chromosomal abnormalities which lead to downe's syndrome; pregnancy screening |
| 12/16/2004 | US20040253618 Expression vector comprising nucleotide sequences coding tumor associated membrane protein for use in diagnosis, prevention and treatment of cell proliferative disorders of urogenital systems |
| 12/16/2004 | US20040253617 Using capsular polysaccharide gene (CPS) sequences to classify streptococcal serotypes; diagnosis and treatment of infection |
| 12/16/2004 | US20040253614 Multicompartment device comprising microarrays which utilizes computer imaging to monitor and analyze genetic hybridization events in liquids; computer diagnostic imaging |
| 12/16/2004 | US20040253612 Selection of proteins using RNA-protein fusions |
| 12/16/2004 | US20040253611 Immunologically active proteins from borrelia burgdorferi |
| 12/16/2004 | US20040253610 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for use in identifying modulators for treatment of inflammatory, cardiovacullar, vision and cancer disorders |
| 12/16/2004 | US20040253609 Prostate cancer markers |
| 12/16/2004 | US20040253600 Multicompartment device for use in monitoring concentration of c-reactive protein in blood; immunoassay |
| 12/16/2004 | US20040253597 Sodium dependent dicarboxylate transport protein for use in identifying modulators for prevention/treatment of hepatic, prostate, splenic, renal diseases, metabolic, circulatory, cancer and aging disorders |
| 12/16/2004 | US20040253596 Bioanalytical recognition surface with optimized recognition element density |
| 12/16/2004 | US20040253595 P53-dependent apoptosis-inducing protein and method of screening for apoptosis regulator |
| 12/16/2004 | US20040253594 Using polymorphic nucleotide sequences to identify regions/quantitative trait loci for natural resistance-associated macrophage protein (NRAMP) genes; prognosticating parasitic infection resistance |
| 12/16/2004 | US20040253593 Quenching methods for background reduction in luminescence-based probe-target binding assays |
| 12/16/2004 | US20040253588 Cytochrome p450 monooxygenase for use in identifying modulators for treatment, diagnosis and prevention of autoimmune/inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, gastrointestinal and liver disorders |
| 12/16/2004 | US20040253585 Methods of detecting polynucleotide kinase and its use as a label |
| 12/16/2004 | US20040253584 Method for separating nucleic acids into populations |
| 12/16/2004 | US20040253579 Natural killer cell line for use as tool in elucidation of mechanism of oncogenesis; identifying modulator for treatment of cell proliferative disorders |
| 12/16/2004 | US20040253578 Solid support comprising immobilized dynamic action reference tools (DART)/bioconjugates for use in isolation and analysis of nucleic acids and polypeptides; drug screening |
| 12/16/2004 | US20040253460 Functionalized silicon compounds and methods for their synthesis and use |
| 12/16/2004 | US20040253367 Size and form of electrode areas defined by precision punching; sample area of electro-chemical sensor is formed by overlap of two similarly-shaped sheets forming a top and bottom, leaving sample area open on all sides to form capillary channel for acquiring samples; uses low-cost, high-speed equipment |
| 12/16/2004 | US20040253246 isolated nucleic acid (DNA, cDNA, or RNA); an expression vector; host cell expressing the vector; a polypeptide; detecting hematogenous micrometastic tumor cells; determining prostate cancer progression |
| 12/16/2004 | US20040253244 Methods for treating pain by administering a nerve growth factor antagonist and an NSAID and compositions containing the same |
| 12/16/2004 | US20040253235 administering interferon-beta (IFN- beta) receptor agonist and tumor associated antigen to increase an immune response against the tumor cells |
| 12/16/2004 | US20040253232 monoclonal antibodies or antigen binding fragments that specifically to six transmembrane epithelial antigens of the prostate (STEAP-1), used for medical diagnosis, prognosis, prophylaxis and/or therapy for cancers |
| 12/16/2004 | US20040253231 monoclonal or polyclonal antibodies having specific reactivity with adenosine triphosphate binding domains, caspase recruitment domains and triosephosphate isomerase domain peptides, used for modulation of apoptosis |
| 12/16/2004 | US20040253220 amino acid sequences of human oxidoreductase enzymes, used for activating expression of elastin; cosmetics |
| 12/16/2004 | US20040253216 Activated checkpoint therapy and methods of use thereof |
| 12/16/2004 | US20040253211 analyzing the expression of claudin-3, claudin-4 and claudin-9; if these genes are under-expressed, the transformed/cancerous cell is a metastatic cell; nucleic acid is transfected into the cancerous cell |
| 12/16/2004 | US20040253207 Methods and compositions for prostate epithelial cell differentiation |
| 12/16/2004 | US20040253184 Lipid containing hydrophilic head group comprising lanthanide-diethylenetriamine pentaacetic acid chelate, linker group is selected from polyethylene glycol, propylene glycol, and polyglycines; imaging enhancement |
| 12/16/2004 | US20040253180 Deuterated nifedipine and penicillins; improved bioavailability |
| 12/16/2004 | US20040253168 Producing nanostructured carbon and carbon monoxide-free hydrogen through decomposition of hydrocarbons in spouted bed reactor containing hydrorefining catalyst, separating solid phases and gas phases, then recovering hydrogen gas; for use in fuel cells, implantable medical equipment |
| 12/16/2004 | US20040253150 An electronic feedback loop between an automatic sample processing system and a weighing device helps to measure the accurate weight of the powdered material |
| 12/16/2004 | US20040253145 An arm arranged to influence a test electrode to a relative movement relative to magazine; quantitative and qualitative analysis of blood sugar, protein in urine etc. |
| 12/16/2004 | US20040253144 Biological specimen having a plurality of marked target zones (MTZs) exhibiting an attribute; a medium storing known locations of the MTZs; a computer software containing instructions |
| 12/16/2004 | US20040253142 Liquid sample assay device |
| 12/16/2004 | US20040253141 Apparatus and method for nucleic acid spatial ordering |
| 12/16/2004 | US20040252745 Device for recording curing temperature history on precast concrete products |
| 12/16/2004 | US20040252586 Measurement of air characteristics in the lower atmosphere |
| 12/16/2004 | US20040252301 Optical interference substrate, target detecting substrate, target detecting apparatus, and target detecting process |
| 12/16/2004 | US20040252299 Apparatus and method for high-throughput preparation and spectroscopic classification and characterization of compositions |
| 12/16/2004 | US20040252292 Method and apparatus for measuring blood sugar |
| 12/16/2004 | US20040252025 Shopping receptacle with in-built scanner |
| 12/16/2004 | US20040251433 Sensor with alignment self compensation |
| 12/16/2004 | US20040251217 Forming two fraction by centrifuging the multi-component fluid disposed in the container, containing the first fraction in a collection area of a first piston with a selected volume of the secong fraction and withdrawing it from the container; kits; whole blood sample, adipose tissue, or a bone marrows |
| 12/16/2004 | US20040251171 Separation apparatus, method of separation, and process for producing separation apparatus |
| 12/16/2004 | US20040251144 Monitoring of gas sensors |
| 12/16/2004 | US20040251139 Traveling wave algorithms to focus and concentrate proteins in gel electrophoresis |
| 12/16/2004 | US20040251137 Preferred angle of slope of electrophoresis is 75 to 88 degrees; combines the high separation resolution of vertical electrophoresis and easy handling of horizontal electrophoresis for performing electrophoresis as a biochemical analysis tool |
| 12/16/2004 | US20040251132 Electrochemical strips for the detection of glucose or of analytes such as lactate, hemoglobin, and hydrogen peroxide, particularly wherein the walls of the adhesive layer touch or overlap with the reagent layer; test strips with small sample chambers |
| 12/16/2004 | US20040251131 Biosensor, biosensor chip, and biosensor device |
| 12/16/2004 | US20040250878 Liquid filling method, liquid filling apparatus, and discharge apparatus |
| 12/16/2004 | US20040250745 Polyethylene glycol-modified semiconductor nanoparticles, method for producing the same, and material for biological diagnosis |
| 12/16/2004 | US20040250612 System for measuring material properties from a moving construction vehicle |
| 12/16/2004 | US20040250606 Device and method for determining the quality of a medium, particularly of a lubricant and/or coolant |
| 12/16/2004 | DE202004015785U1 Gas sampler for gases containing environmental smells has inlet tube with throttle regulation to gas sample bag |
| 12/16/2004 | DE20023542U1 Handy measurement instrument determining state of oils and fats, measures dielectric constant for indication, with capacitor in oscillatory circuit and temperature compensation for use in e.g. hot motor- or frying oils |
| 12/16/2004 | DE10324742A1 Laboratory diagnosis of intrathecal immunoglobulin synthesis, multiple sclerosis and meningitis comprises measuring concentration of free kappa immunoglobulin light chains in cerebrospinal fluid |
| 12/16/2004 | DE10324315A1 Fuel processing system for supplying hydrogen to fuel cell has control system with flame ionization sensor and burner for raw fuel and reformed gas for monitoring quality of reformed gas |
| 12/16/2004 | DE10322912A1 Verfahren zum Nachweis von Nukleinsäuren A method for detecting nucleic acids |
| 12/16/2004 | DE10254062B4 Verfahren und Vorrichtung zur Bestimmung von Schüttgutparametern Method and apparatus for the determination of bulk parameters |
| 12/16/2004 | CA2568806A1 Methods for detecting and treating cancer using podocalyxin and/or endoglycan |
| 12/16/2004 | CA2528851A1 Extracellular aspergillus polypeptides |
| 12/16/2004 | CA2528508A1 System and method for multidimensional evaluation of combinations of compositions |
| 12/16/2004 | CA2528362A1 Method and device for analysing a biological liquid |
| 12/16/2004 | CA2528088A1 Method for diagnosing cancer and method for determining cancer susceptibility |
| 12/16/2004 | CA2527799A1 Methods for identifying modulators of kinesin activity |
| 12/16/2004 | CA2527728A1 Micropositioning cells for tissue engineering |
| 12/16/2004 | CA2527650A1 Method for identification of glycosylated polypeptides |
| 12/16/2004 | CA2527317A1 A library of phylogenetically related sequences |
| 12/16/2004 | CA2527229A1 Integrated test element for a one-time drawing and analyzing of a sample to be analysed |
| 12/16/2004 | CA2526638A1 Method of mitigating the adverse effects of il-2 |
| 12/16/2004 | CA2526515A1 Methods for screening inhibitors of apoptosis |
| 12/16/2004 | CA2526012A1 Screen for novel protein inhibitors based upon engineered cell line containing an inducible overactivity gene and compensatory gene |